Ligand Pharmaceuticals
LGND
#3601
Rank
โ‚ฌ3.12 B
Marketcap
158,78ย โ‚ฌ
Share price
-1.93%
Change (1 day)
34.65%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ0.45 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are โ‚ฌ0.45 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ0.10 B37.04%
2023-12-31โ‚ฌ78.06 M-49.3%
2022-12-31โ‚ฌ0.15 B-63.4%
2021-12-31โ‚ฌ0.42 B-20.73%
2020-12-31โ‚ฌ0.53 B-18.3%
2019-12-31โ‚ฌ0.64 B6.18%
2018-12-31โ‚ฌ0.61 B190.86%
2017-12-31โ‚ฌ0.21 B-4.11%
2016-12-31โ‚ฌ0.21 B6.06%
2015-12-31โ‚ฌ0.20 B7.68%
2014-12-31โ‚ฌ0.19 B381.45%
2013-12-31โ‚ฌ39.89 M-32.14%
2012-12-31โ‚ฌ58.79 M-32.07%
2011-12-31โ‚ฌ86.54 M43.17%
2010-12-31โ‚ฌ60.45 M-37.27%
2009-12-31โ‚ฌ96.36 M-25.9%
2008-12-31โ‚ฌ0.13 B31.72%
2007-12-31โ‚ฌ98.73 M-56.38%
2006-12-31โ‚ฌ0.22 B-36.91%
2005-12-31โ‚ฌ0.35 B19.36%
2004-12-31โ‚ฌ0.30 B7.64%
2003-12-31โ‚ฌ0.27 B44.94%
2002-12-31โ‚ฌ0.19 B-2.96%
2001-12-31โ‚ฌ0.19 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
โ‚ฌ69.16 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
โ‚ฌ69.45 M-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ52.63 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ66.68 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ99.31 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ78.23 B 17,196.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ67.24 B 14,766.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
โ‚ฌ11.89 B 2,530.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ97.51 B 21,460.73%๐Ÿ‡บ๐Ÿ‡ธ USA